While non-V600E BRAF mutations in melanoma were found to be more common in older patients, these mutations consistently represented between 10 and 20% of BRAF mutations in the 20–29, 30–39, 40–49, and 50–59 age groups [36]. The gene discussed is BRAF; the disease is melanoma.